Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high…
Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
Audiobooks on Spotify
Don’t judge this Spotify feature by its cover.
Kouvr Fashion
Don’t be fooled by this website.
Magic Styler’s Refund Policy
This risk-free trial might have you pulling your hair out.
FTC Proposes New Rule Targeting Deceptive Income Claims in MLM Industry
Proposed new earnings claim rule comes three years after TINA.org comment to FTC.
Period Stigma and the Deceptive Marketing of Menstrual Products
How negative feelings surrounding menstruation have influenced period product marketing.